View ValuationMEDINET 将来の成長Future 基準チェック /06現在、 MEDINETの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Life Sciences 収益成長24.7%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Feb 09MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year ending September 30, 2023, the company expects net sales of JPY 728 million, operating loss of JPY 1,766 million and loss of JPY 1,761 million or JPY 8.32 per basic share.お知らせ • Nov 12MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year, the company expects net sales of JPY 728 million, Operating loss of JPY 1,766 million, loss of JPY 1,761 million and basic loss per share of JPY 8.32.お知らせ • May 13MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the year, the company expects net sales of JPY 752 million, Operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.お知らせ • Feb 11MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the period, the company expects net sales of JPY 752 million, operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.すべての更新を表示Recent updatesお知らせ • Dec 04MEDINET Co., Ltd. announced that it expects to receive ¥12.39 million in funding from Macquarie Bank LimitedMEDINET Co., Ltd announced a private placement to issue 590,000 units of 20th Stock Acquisition rights at a price of ¥21 per stock acquisition right for aggregate gross proceeds of ¥12,390,000 on December 3, 2025. The transaction has been approved by the board of directors and is expected to close on December 23, 2025. The exercise period for the stock acquisition rights will be between December 24, 2025 to December 23, 2027. The transaction will include participation from Macquarie Bank Limited.お知らせ • Nov 13MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2025MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2025.お知らせ • Nov 05MEDINET Co., Ltd. to Report Fiscal Year 2025 Results on Nov 13, 2025MEDINET Co., Ltd. announced that they will report fiscal year 2025 results on Nov 13, 2025お知らせ • Jul 08MEDINET Co., Ltd. to Report Q3, 2025 Results on Aug 12, 2025MEDINET Co., Ltd. announced that they will report Q3, 2025 results on Aug 12, 2025New Risk • Jun 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Minor Risk Market cap is less than US$100m (JP¥10.3b market cap, or US$71.2m).お知らせ • Apr 15MEDINET Co., Ltd. to Report Q2, 2025 Results on May 13, 2025MEDINET Co., Ltd. announced that they will report Q2, 2025 results on May 13, 2025お知らせ • Jan 18MEDINET Co., Ltd. to Report Q1, 2025 Results on Feb 13, 2025MEDINET Co., Ltd. announced that they will report Q1, 2025 results on Feb 13, 2025お知らせ • Nov 13MEDINET Co., Ltd., Annual General Meeting, Dec 18, 2024MEDINET Co., Ltd., Annual General Meeting, Dec 18, 2024.New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (JP¥12.1b market cap, or US$81.0m).お知らせ • Jun 22MEDINET Co., Ltd. to Report Q3, 2024 Results on Aug 09, 2024MEDINET Co., Ltd. announced that they will report Q3, 2024 results on Aug 09, 2024お知らせ • Jan 11MEDINET Co., Ltd. to Report Q1, 2024 Results on Feb 09, 2024MEDINET Co., Ltd. announced that they will report Q1, 2024 results on Feb 09, 2024お知らせ • Nov 13MEDINET Co., Ltd., Annual General Meeting, Dec 21, 2023MEDINET Co., Ltd., Annual General Meeting, Dec 21, 2023.New Risk • Nov 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Share price has been highly volatile over the past 3 months (7.8% average weekly change). Minor Risks Shareholders have been diluted in the past year (9.6% increase in shares outstanding). Market cap is less than US$100m (JP¥11.4b market cap, or US$75.5m).New Risk • Aug 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (5.2% average weekly change). Shareholders have been diluted in the past year (4.4% increase in shares outstanding). Market cap is less than US$100m (JP¥11.3b market cap, or US$77.6m).New Risk • Jul 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.3b (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Market cap is less than US$100m (JP¥14.3b market cap, or US$99.4m).New Risk • Jun 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risk Shareholders have been diluted in the past year (2.6% increase in shares outstanding).お知らせ • Jun 17MEDINET Co., Ltd. to Report Q3, 2023 Results on Jul 31, 2023MEDINET Co., Ltd. announced that they will report Q3, 2023 results on Jul 31, 2023お知らせ • Feb 09MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year ending September 30, 2023, the company expects net sales of JPY 728 million, operating loss of JPY 1,766 million and loss of JPY 1,761 million or JPY 8.32 per basic share.お知らせ • Dec 26MEDINET Co., Ltd. to Report Q1, 2023 Results on Feb 09, 2023MEDINET Co., Ltd. announced that they will report Q1, 2023 results on Feb 09, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Kouichiro Yoshino was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Nov 12MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year, the company expects net sales of JPY 728 million, Operating loss of JPY 1,766 million, loss of JPY 1,761 million and basic loss per share of JPY 8.32.お知らせ • Nov 11MEDINET Co., Ltd., Annual General Meeting, Dec 15, 2022MEDINET Co., Ltd., Annual General Meeting, Dec 15, 2022.お知らせ • Sep 24MEDINET Co., Ltd. to Report Q4, 2022 Results on Nov 11, 2022MEDINET Co., Ltd. announced that they will report Q4, 2022 results on Nov 11, 2022お知らせ • Jun 16MEDINET Co., Ltd. to Report Q3, 2022 Results on Aug 10, 2022MEDINET Co., Ltd. announced that they will report Q3, 2022 results on Aug 10, 2022お知らせ • May 13MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the year, the company expects net sales of JPY 752 million, Operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Kouichiro Yoshino was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08MEDINET Co., Ltd. to Report Q2, 2022 Results on May 12, 2022MEDINET Co., Ltd. announced that they will report Q2, 2022 results on May 12, 2022お知らせ • Feb 11MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the period, the company expects net sales of JPY 752 million, operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.お知らせ • Sep 02MEDINET Co., Ltd. announced that it has received ¥22.44 million in funding from Macquarie Bank Limited, Investment ArmOn September 1, 2021, MEDINET Co., Ltd. closed the transaction.お知らせ • Aug 17MEDINET Co., Ltd. announced that it expects to receive ¥22.44 million in funding from Macquarie Bank Limited, Investment ArmMEDINET Co., Ltd. announced a private placement of 340,000 18th stock acquisition rights at ¥66 per stock acquisition right for gross proceeds of ¥22,440,000 on August 16, 2021. The transaction included participation from returning investor Macquarie Bank Limited, Investment Arm. The potential shares from the issuance of stock acquisition rights will be 34,000,000 shares. The initial exercise price of stock acquisition rights ¥78.85 for a period from September 2, 2021 to September 1, 2023. The transaction will happen through third party allocation. The company will incur issuance expenses with respect to the transaction including registration and license taxes, attorney's fees, fair value calculation costs for the stock acquisition rights, securities registration statement preparation costs, etc. The issue date for stock acquisition rights will be September 1, 2021. The transaction has been approved at board of directors’ meeting of the company.Is New 90 Day High Low • Feb 18New 90-day high: JP¥72.00The company is up 6.0% from its price of JP¥68.00 on 20 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Life Sciences industry, which is up 4.0% over the same period.Is New 90 Day High Low • Dec 07New 90-day low: JP¥61.00The company is down 39% from its price of JP¥100.00 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 8.0% over the same period.お知らせ • Nov 14MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2020MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2020.お知らせ • Sep 23MEDINET Co., Ltd. to Report Fiscal Year 2020 Results on Nov 06, 2020MEDINET Co., Ltd. announced that they will report fiscal year 2020 results on Nov 06, 2020お知らせ • Sep 08MEDINET Co., Ltd. announced that it has received ¥24.13 million in funding from Macquarie Bank Limited, Investment ArmOn September 7, 2020, MEDINET Co., Ltd. (TSE:2370) closed the transaction.お知らせ • Aug 22MEDINET Co., Ltd. announced that it expects to receive ¥24.13 million in funding from Macquarie Bank Limited, Investment ArmMEDINET Co., Ltd. (TSE:2370) announced a private placement of 190,000 units 17th stock acquisition rights at a price of ¥127 per share for the gross proceeds of ¥24,130,000 with returning investor Macquarie Bank Limited, Investment Arm on August 21, 2020. The 17th stock acquisition rights will be converted into 19,000,000 shares at a price of ¥100 per stock acquisition right. The minimum exercise price of stock acquisition rights is ¥54 and the initial exercise price ¥101.12. The exercise period is from September 8, 2020 to September 7, 2022. The transaction has been approved by board of directors of the company. The transaction is expected to close on September 7, 2020.お知らせ • Jul 08MEDINET Co., Ltd. announced that it has received ¥24.436 million in funding from Macquarie Bank Limited, Investment ArmOn July 6, 2020, MEDINET Co., Ltd. (TSE:2370) closed the transaction.お知らせ • Jun 29MEDINET Co., Ltd. to Report Q3, 2020 Results on Aug 07, 2020MEDINET Co., Ltd. announced that they will report Q3, 2020 results on Aug 07, 2020お知らせ • Jun 20MEDINET Co., Ltd. announced that it expects to receive ¥24.436 million in funding from Macquarie Bank Limited, Investment ArmMEDINET Co., Ltd. (TSE:2370) announced a private placement of 164,000 units 16th stock acquisition rights at a price of ¥149 per share for the gross proceeds of ¥24,436,000 on June 19, 2020. The transaction will include participation from returning investor Macquarie Bank Limited, Investment Arm. The transaction has been approved by board of directors. The 16th stock acquisition rights will be converted into 16,400,000 shares at a price of ¥100 per stock acquisition right. The minimum exercise price of stock acquisition rights is ¥62 and the initial exercise price ¥113.78. The exercise period is from July 7, 2020, to July 6, 2022. The company will pay issuance expenses ¥15,000,000 in the transaction. The transaction is expected to close on July 6, 2020. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、MEDINET は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TSE:2370 - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/2018998-3,048-2,723-2,499N/A6/30/20181,160-3,797N/AN/AN/A3/31/20181,353-3,716-2,427-2,263N/A12/31/20171,548-3,421N/AN/AN/A9/30/20171,704-2,603-1,354-1,333N/A6/30/20171,819-1,974N/AN/AN/A3/31/20171,876-1,843-1,563-1,529N/A12/31/20161,895-1,580N/AN/AN/A9/30/20161,909-1,643-1,145-1,088N/A6/30/20161,825-1,692N/AN/AN/A3/31/20161,737-1,865-1,766-1,220N/A12/31/20151,731-1,786N/AN/AN/A9/30/20151,674-1,712-2,542-1,567N/A6/30/20151,679-2,051N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 2370の予測収益成長が 貯蓄率 ( 0.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 2370の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 2370の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 2370の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 2370の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 2370の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 20:33終値2026/05/22 00:00収益2018/09/30年間収益2018/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MEDINET Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kiyokazu YamazakiIchiyoshi Research Institute Inc.
お知らせ • Feb 09MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year ending September 30, 2023, the company expects net sales of JPY 728 million, operating loss of JPY 1,766 million and loss of JPY 1,761 million or JPY 8.32 per basic share.
お知らせ • Nov 12MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year, the company expects net sales of JPY 728 million, Operating loss of JPY 1,766 million, loss of JPY 1,761 million and basic loss per share of JPY 8.32.
お知らせ • May 13MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the year, the company expects net sales of JPY 752 million, Operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.
お知らせ • Feb 11MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the period, the company expects net sales of JPY 752 million, operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.
お知らせ • Dec 04MEDINET Co., Ltd. announced that it expects to receive ¥12.39 million in funding from Macquarie Bank LimitedMEDINET Co., Ltd announced a private placement to issue 590,000 units of 20th Stock Acquisition rights at a price of ¥21 per stock acquisition right for aggregate gross proceeds of ¥12,390,000 on December 3, 2025. The transaction has been approved by the board of directors and is expected to close on December 23, 2025. The exercise period for the stock acquisition rights will be between December 24, 2025 to December 23, 2027. The transaction will include participation from Macquarie Bank Limited.
お知らせ • Nov 13MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2025MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2025.
お知らせ • Nov 05MEDINET Co., Ltd. to Report Fiscal Year 2025 Results on Nov 13, 2025MEDINET Co., Ltd. announced that they will report fiscal year 2025 results on Nov 13, 2025
お知らせ • Jul 08MEDINET Co., Ltd. to Report Q3, 2025 Results on Aug 12, 2025MEDINET Co., Ltd. announced that they will report Q3, 2025 results on Aug 12, 2025
New Risk • Jun 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Minor Risk Market cap is less than US$100m (JP¥10.3b market cap, or US$71.2m).
お知らせ • Apr 15MEDINET Co., Ltd. to Report Q2, 2025 Results on May 13, 2025MEDINET Co., Ltd. announced that they will report Q2, 2025 results on May 13, 2025
お知らせ • Jan 18MEDINET Co., Ltd. to Report Q1, 2025 Results on Feb 13, 2025MEDINET Co., Ltd. announced that they will report Q1, 2025 results on Feb 13, 2025
お知らせ • Nov 13MEDINET Co., Ltd., Annual General Meeting, Dec 18, 2024MEDINET Co., Ltd., Annual General Meeting, Dec 18, 2024.
New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (JP¥12.1b market cap, or US$81.0m).
お知らせ • Jun 22MEDINET Co., Ltd. to Report Q3, 2024 Results on Aug 09, 2024MEDINET Co., Ltd. announced that they will report Q3, 2024 results on Aug 09, 2024
お知らせ • Jan 11MEDINET Co., Ltd. to Report Q1, 2024 Results on Feb 09, 2024MEDINET Co., Ltd. announced that they will report Q1, 2024 results on Feb 09, 2024
お知らせ • Nov 13MEDINET Co., Ltd., Annual General Meeting, Dec 21, 2023MEDINET Co., Ltd., Annual General Meeting, Dec 21, 2023.
New Risk • Nov 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Share price has been highly volatile over the past 3 months (7.8% average weekly change). Minor Risks Shareholders have been diluted in the past year (9.6% increase in shares outstanding). Market cap is less than US$100m (JP¥11.4b market cap, or US$75.5m).
New Risk • Aug 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (5.2% average weekly change). Shareholders have been diluted in the past year (4.4% increase in shares outstanding). Market cap is less than US$100m (JP¥11.3b market cap, or US$77.6m).
New Risk • Jul 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: JP¥14.3b (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Market cap is less than US$100m (JP¥14.3b market cap, or US$99.4m).
New Risk • Jun 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2018 fiscal period end). Minor Risk Shareholders have been diluted in the past year (2.6% increase in shares outstanding).
お知らせ • Jun 17MEDINET Co., Ltd. to Report Q3, 2023 Results on Jul 31, 2023MEDINET Co., Ltd. announced that they will report Q3, 2023 results on Jul 31, 2023
お知らせ • Feb 09MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year ending September 30, 2023, the company expects net sales of JPY 728 million, operating loss of JPY 1,766 million and loss of JPY 1,761 million or JPY 8.32 per basic share.
お知らせ • Dec 26MEDINET Co., Ltd. to Report Q1, 2023 Results on Feb 09, 2023MEDINET Co., Ltd. announced that they will report Q1, 2023 results on Feb 09, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Kouichiro Yoshino was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 12MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2023. For the year, the company expects net sales of JPY 728 million, Operating loss of JPY 1,766 million, loss of JPY 1,761 million and basic loss per share of JPY 8.32.
お知らせ • Nov 11MEDINET Co., Ltd., Annual General Meeting, Dec 15, 2022MEDINET Co., Ltd., Annual General Meeting, Dec 15, 2022.
お知らせ • Sep 24MEDINET Co., Ltd. to Report Q4, 2022 Results on Nov 11, 2022MEDINET Co., Ltd. announced that they will report Q4, 2022 results on Nov 11, 2022
お知らせ • Jun 16MEDINET Co., Ltd. to Report Q3, 2022 Results on Aug 10, 2022MEDINET Co., Ltd. announced that they will report Q3, 2022 results on Aug 10, 2022
お知らせ • May 13MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the year, the company expects net sales of JPY 752 million, Operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Kouichiro Yoshino was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08MEDINET Co., Ltd. to Report Q2, 2022 Results on May 12, 2022MEDINET Co., Ltd. announced that they will report Q2, 2022 results on May 12, 2022
お知らせ • Feb 11MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022MEDINET Co., Ltd. provided earnings guidance for the year ending September 30, 2022. For the period, the company expects net sales of JPY 752 million, operating loss of JPY 1,755 million, loss of JPY 1,761 million and basic loss per share of JPY 9.85.
お知らせ • Sep 02MEDINET Co., Ltd. announced that it has received ¥22.44 million in funding from Macquarie Bank Limited, Investment ArmOn September 1, 2021, MEDINET Co., Ltd. closed the transaction.
お知らせ • Aug 17MEDINET Co., Ltd. announced that it expects to receive ¥22.44 million in funding from Macquarie Bank Limited, Investment ArmMEDINET Co., Ltd. announced a private placement of 340,000 18th stock acquisition rights at ¥66 per stock acquisition right for gross proceeds of ¥22,440,000 on August 16, 2021. The transaction included participation from returning investor Macquarie Bank Limited, Investment Arm. The potential shares from the issuance of stock acquisition rights will be 34,000,000 shares. The initial exercise price of stock acquisition rights ¥78.85 for a period from September 2, 2021 to September 1, 2023. The transaction will happen through third party allocation. The company will incur issuance expenses with respect to the transaction including registration and license taxes, attorney's fees, fair value calculation costs for the stock acquisition rights, securities registration statement preparation costs, etc. The issue date for stock acquisition rights will be September 1, 2021. The transaction has been approved at board of directors’ meeting of the company.
Is New 90 Day High Low • Feb 18New 90-day high: JP¥72.00The company is up 6.0% from its price of JP¥68.00 on 20 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Life Sciences industry, which is up 4.0% over the same period.
Is New 90 Day High Low • Dec 07New 90-day low: JP¥61.00The company is down 39% from its price of JP¥100.00 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 8.0% over the same period.
お知らせ • Nov 14MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2020MEDINET Co., Ltd., Annual General Meeting, Dec 17, 2020.
お知らせ • Sep 23MEDINET Co., Ltd. to Report Fiscal Year 2020 Results on Nov 06, 2020MEDINET Co., Ltd. announced that they will report fiscal year 2020 results on Nov 06, 2020
お知らせ • Sep 08MEDINET Co., Ltd. announced that it has received ¥24.13 million in funding from Macquarie Bank Limited, Investment ArmOn September 7, 2020, MEDINET Co., Ltd. (TSE:2370) closed the transaction.
お知らせ • Aug 22MEDINET Co., Ltd. announced that it expects to receive ¥24.13 million in funding from Macquarie Bank Limited, Investment ArmMEDINET Co., Ltd. (TSE:2370) announced a private placement of 190,000 units 17th stock acquisition rights at a price of ¥127 per share for the gross proceeds of ¥24,130,000 with returning investor Macquarie Bank Limited, Investment Arm on August 21, 2020. The 17th stock acquisition rights will be converted into 19,000,000 shares at a price of ¥100 per stock acquisition right. The minimum exercise price of stock acquisition rights is ¥54 and the initial exercise price ¥101.12. The exercise period is from September 8, 2020 to September 7, 2022. The transaction has been approved by board of directors of the company. The transaction is expected to close on September 7, 2020.
お知らせ • Jul 08MEDINET Co., Ltd. announced that it has received ¥24.436 million in funding from Macquarie Bank Limited, Investment ArmOn July 6, 2020, MEDINET Co., Ltd. (TSE:2370) closed the transaction.
お知らせ • Jun 29MEDINET Co., Ltd. to Report Q3, 2020 Results on Aug 07, 2020MEDINET Co., Ltd. announced that they will report Q3, 2020 results on Aug 07, 2020
お知らせ • Jun 20MEDINET Co., Ltd. announced that it expects to receive ¥24.436 million in funding from Macquarie Bank Limited, Investment ArmMEDINET Co., Ltd. (TSE:2370) announced a private placement of 164,000 units 16th stock acquisition rights at a price of ¥149 per share for the gross proceeds of ¥24,436,000 on June 19, 2020. The transaction will include participation from returning investor Macquarie Bank Limited, Investment Arm. The transaction has been approved by board of directors. The 16th stock acquisition rights will be converted into 16,400,000 shares at a price of ¥100 per stock acquisition right. The minimum exercise price of stock acquisition rights is ¥62 and the initial exercise price ¥113.78. The exercise period is from July 7, 2020, to July 6, 2022. The company will pay issuance expenses ¥15,000,000 in the transaction. The transaction is expected to close on July 6, 2020.